Evidence map›Paper›PMID 39844841›Full record

ArticleFrontiers in cellular and infection microbiology2024

Application of metagenomic next-generation sequencing in the diagnosis of post-stroke infections: a case series study using multiple sample types.

Xiaopu Chen, Yong Liang, Wei Yang, Wenzhen He, Zhiqiang Xing, Shunxian Li, Shaoyu Cai, Jiping Fu, Xiaotang Peng, Manli Chen and 1 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaopu Chen *Department of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Yong Liang *Department of Research and Development, Shenzhen Xbiome Biotech Co. Ltd., Shenzhen, China.
Wei Yang *GeneMind Biosciences Company Limited, Shenzhen, Guangdong, China.
Wenzhen HeDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Zhiqiang XingDepartment of Diagnosis Technology Transformation, SK Medical Technology Co, Ltd, Beijing, China.
Shunxian LiDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Shaoyu CaiDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Jiping FuDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Xiaotang PengDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Manli ChenDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Jiaming WuDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metagenomic high-throughput sequencing (mNGS) represents a powerful tool for detecting nucleic acids from various pathogens, such as bacteria, fungi, viruses and parasites, in clinical samples. Despite its extensively employed in the pathogen diagnosis for various infectious diseases, its application in diagnosing stroke-related infection, and its potential impact on clinical decision-making, anti-infection treatment, clinical intervention, and patient prognosis remain insufficiently explored. Additionally, while mNGS offers promising potential, it facts limitations related to sensitivity, specificity, cost, and standardization, which could influence its integration into routine clinical practice. Methods: We retrospectively analyzed 18 stroke patients admitted to the First Affiliated Hospital of Medical College of Shantou University from January to February 2023, comparing culture-based methods with mNGS detection, and assessing its significance in etiological diagnosis. Additionally, we evaluated the performance differences among various sequencing platforms. Results: Among the 18 stroke patients enrolled, pulmonary infections were identified in 7 cases, urinary tract infections in 1 case, central nervous system infections in 10 cases, and combined pulmonary and central nervous system infections in 2 cases, with 2 cases yielding negative results. mNGS detected pathogens in 13 cases, aligning with clinical diagnoses (75% concordance), whereas culture-based methods yielded positive results in only 6 cases (22% concordance). Importantly, for 9 of the 18 patients, adjustments to anti-infective treatment regimens based on mNGS results led to improved symptomatic relief and infection control. This suggests that mNGS can contribute to more timely and precise treatment modifications, particularly for infections with low pathogen loads, potentially enhancing clinical outcomes. Conclusion: Our findings highlights the utility of mNGS in diagnosing stroke-associated infections by providing a more comprehensive etiological diagnosis compared to traditional method. While mNGS shows promise in enhancing diagnostic accuracy and guiding clinical treatment, it high cost and technical challenges need addressing before widespread clinical adoption. Future research should focus on optimizing mNGS protocols, integration it with convertional diagnostic tools, and evaluating its cost-effectiveness and clinical impact through larger, multicentric studies.

Indexed as

High-Throughput Nucleotide SequencingMetagenomicsStrokeAdultAgedAged, 80 and overBacteriaCentral Nervous System InfectionsFemaleHumansMaleMiddle AgedRetrospective StudiesSensitivity and SpecificityUrinary Tract Infectionsdepartment of neurologydiagnostic effectnext-generation sequencingstroke-related infectionstreatment

Identifiers

PMID39844841
PMCPMC11751054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.